Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00360399 · ClinicalTrials.gov registry record · NA

Identifying Factors That Predict Antidepressant Treatment Response

A NA study of Depression, sponsored by Emory University.

Completed
Registry status
NA
Development phase
344
Enrollment target
2
Study locations

NCT00360399 is a NA study of Depression that has completed, run by Emory University. The registered enrollment target is 344 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (56% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00360399, a NA study of Depression, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
344 participants
Enrollment target
2
Study locations

Study Summary

This study will compare different treatments for depression in order to identify which factors predict effectiveness, and will include a companion study which investigates combining treatments and long term effectiveness.

Conditions Studied

Depression

Interventions

  • DRUG Duloxetine
  • DRUG Escitalopram
  • BEHAVIORAL Cognitive behavioral therapy (CBT)

Study Locations (2)

Georgia

  • Emory University Mood and Anxiety Disorders Program - Atlanta
  • Emory University School of Medicine - Atlanta

Trial Details

FieldValue
Enrollment Target 344 participants
Start Date 2006-08
Est. Completion 2015-04
Phase NA

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00360399

The ClinicalTrials.gov registry entry for NCT00360399 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 344 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (56% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 3 interventions - of which Duloxetine is the first listed.

NCT00360399 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT00360399 about?

NCT00360399 is a clinical study titled "Identifying Factors That Predict Antidepressant Treatment Response". This study will compare different treatments for depression in order to identify which factors predict effectiveness, and will include a companion study which investigates combining treatments and long term effectiveness.

What is the current status of trial NCT00360399?

This trial is currently completed. It is a NA study. The enrollment target is 344 participants. The study started on 2006-08. Estimated completion is 2015-04.

What conditions does trial NCT00360399 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT00360399?

The interventions under investigation include: Duloxetine (DRUG), Escitalopram (DRUG), Cognitive behavioral therapy (CBT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00360399?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00360399 being conducted?

This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Depression

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.